25 XP   0   0   10

Star Combo Pharma Ltd
Buy, Hold or Sell?

Let's analyse Star Combo Pharma Ltd together

PenkeI guess you are interested in Star Combo Pharma Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Star Combo Pharma Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Star Combo Pharma Ltd

I send you an email if I find something interesting about Star Combo Pharma Ltd.

Quick analysis of Star Combo Pharma Ltd (30 sec.)










What can you expect buying and holding a share of Star Combo Pharma Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.25
Expected worth in 1 year
A$0.25
How sure are you?
34.5%

+ What do you gain per year?

Total Gains per Share
A$0.01
Return On Investment
5.3%

For what price can you sell your share?

Current Price per Share
A$0.12
Expected price per share
A$0.12 - A$0.12
How sure are you?
50%

1. Valuation of Star Combo Pharma Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.12

Intrinsic Value Per Share

A$1.11 - A$1.35

Total Value Per Share

A$1.36 - A$1.60

2. Growth of Star Combo Pharma Ltd (5 min.)




Is Star Combo Pharma Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$21.7m$22.1m-$418.9k-1.9%

How much money is Star Combo Pharma Ltd making?

Current yearPrevious yearGrowGrow %
Making money$118.2k-$1.2m$1.3m1,142.5%
Net Profit Margin1.9%-22.0%--

How much money comes from the company's main activities?

3. Financial Health of Star Combo Pharma Ltd (5 min.)




4. Comparing to competitors in the Household & Personal Products industry (5 min.)




  Industry Rankings (Household & Personal Products)  


Richest
#149 / 184

Most Revenue
#161 / 184

Most Profit
#126 / 184

Most Efficient
#112 / 184

What can you expect buying and holding a share of Star Combo Pharma Ltd? (5 min.)

Welcome investor! Star Combo Pharma Ltd's management wants to use your money to grow the business. In return you get a share of Star Combo Pharma Ltd.

What can you expect buying and holding a share of Star Combo Pharma Ltd?

First you should know what it really means to hold a share of Star Combo Pharma Ltd. And how you can make/lose money.

Speculation

The Price per Share of Star Combo Pharma Ltd is A$0.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Star Combo Pharma Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Star Combo Pharma Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.25. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Star Combo Pharma Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.000.5%0.000.5%-0.01-5.0%0.00-2.7%0.00-2.3%
Usd Book Value Change Per Share0.000.0%0.000.9%0.00-3.4%0.003.4%0.014.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.9%0.00-3.4%0.003.4%0.014.6%
Usd Price Per Share0.09-0.07-0.11-0.20-0.19-
Price to Earnings Ratio38.95-32.83--10.03--1,927.60--1,331.99-
Price-to-Total Gains Ratio36.21-6.84--90.41--41.67-
Price to Book Ratio0.58-0.47-0.69-1.46-1.64-
Price-to-Total Gains Ratio36.21-6.84--90.41--41.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.077988
Number of shares12822
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (12822 shares)13.2151.62
Gains per Year (12822 shares)52.83206.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1053430206196
20106960413402
301581490619608
402112020826814
50264255010321020
60317308012391226
70370361014451432
80423414016521638
90475467018581844
100528520020652050

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%4.08.00.033.3%8.012.00.040.0%12.017.00.041.4%12.017.00.041.4%
Book Value Change Per Share2.00.02.050.0%4.04.04.033.3%7.06.07.035.0%10.08.011.034.5%10.08.011.034.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share2.00.02.050.0%4.04.04.033.3%7.06.07.035.0%10.08.011.034.5%10.08.011.034.5%

Fundamentals of Star Combo Pharma Ltd

About Star Combo Pharma Ltd

Star Combo Pharma Limited engages in the manufacturing and distribution of health food products and nutritional supplements in Australia and China. The company operates through two segments: Star Combo and Austoyou Retail. It develops, manufactures, markets, and sells natural health supplements and skin care products. The company provides its products through e-commerce platform primarily to Chinese health product consumers. Star Combo Pharma Limited was founded in 2004 and is headquartered in Smithfield, Australia.

Fundamental data was last updated by Penke on 2024-04-24 23:25:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Star Combo Pharma Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Star Combo Pharma Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Star Combo Pharma Ltd to the Household & Personal Products industry mean.
  • A Net Profit Margin of 1.0% means that $0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Star Combo Pharma Ltd:

  • The MRQ is 1.0%. The company is making a profit. +1
  • The TTM is 1.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.0%TTM1.9%-0.9%
TTM1.9%YOY-22.0%+23.8%
TTM1.9%5Y-12.0%+13.9%
5Y-12.0%10Y-9.7%-2.4%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0%4.2%-3.2%
TTM1.9%4.5%-2.6%
YOY-22.0%4.6%-26.6%
5Y-12.0%5.0%-17.0%
10Y-9.7%6.1%-15.8%
1.1.2. Return on Assets

Shows how efficient Star Combo Pharma Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Star Combo Pharma Ltd to the Household & Personal Products industry mean.
  • 0.3% Return on Assets means that Star Combo Pharma Ltd generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Star Combo Pharma Ltd:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.4%-0.1%
TTM0.4%YOY-4.7%+5.1%
TTM0.4%5Y-2.6%+3.0%
5Y-2.6%10Y-2.1%-0.5%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%1.4%-1.1%
TTM0.4%1.5%-1.1%
YOY-4.7%1.6%-6.3%
5Y-2.6%1.8%-4.4%
10Y-2.1%2.1%-4.2%
1.1.3. Return on Equity

Shows how efficient Star Combo Pharma Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Star Combo Pharma Ltd to the Household & Personal Products industry mean.
  • 0.4% Return on Equity means Star Combo Pharma Ltd generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Star Combo Pharma Ltd:

  • The MRQ is 0.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.5%-0.2%
TTM0.5%YOY-5.8%+6.3%
TTM0.5%5Y-3.2%+3.7%
5Y-3.2%10Y-2.2%-1.0%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%2.8%-2.4%
TTM0.5%3.0%-2.5%
YOY-5.8%3.2%-9.0%
5Y-3.2%3.3%-6.5%
10Y-2.2%3.6%-5.8%

1.2. Operating Efficiency of Star Combo Pharma Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Star Combo Pharma Ltd is operating .

  • Measures how much profit Star Combo Pharma Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Star Combo Pharma Ltd to the Household & Personal Products industry mean.
  • An Operating Margin of 1.3% means the company generated $0.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Star Combo Pharma Ltd:

  • The MRQ is 1.3%. The company is operating less efficient.
  • The TTM is 4.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM4.5%-3.2%
TTM4.5%YOY0.9%+3.5%
TTM4.5%5Y-2.4%+6.9%
5Y-2.4%10Y-4.9%+2.5%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%7.3%-6.0%
TTM4.5%4.9%-0.4%
YOY0.9%7.2%-6.3%
5Y-2.4%7.2%-9.6%
10Y-4.9%8.2%-13.1%
1.2.2. Operating Ratio

Measures how efficient Star Combo Pharma Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are $0.99 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Star Combo Pharma Ltd:

  • The MRQ is 0.987. The company is less efficient in keeping operating costs low.
  • The TTM is 0.958. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.987TTM0.958+0.029
TTM0.958YOY1.107-0.149
TTM0.9585Y1.050-0.092
5Y1.05010Y0.961+0.088
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9871.272-0.285
TTM0.9581.191-0.233
YOY1.1071.114-0.007
5Y1.0501.138-0.088
10Y0.9611.052-0.091

1.3. Liquidity of Star Combo Pharma Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Star Combo Pharma Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Household & Personal Products industry mean).
  • A Current Ratio of 5.67 means the company has $5.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Star Combo Pharma Ltd:

  • The MRQ is 5.674. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.927. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.674TTM4.927+0.748
TTM4.927YOY5.436-0.509
TTM4.9275Y5.676-0.749
5Y5.67610Y4.942+0.734
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6741.651+4.023
TTM4.9271.702+3.225
YOY5.4361.628+3.808
5Y5.6761.693+3.983
10Y4.9421.708+3.234
1.3.2. Quick Ratio

Measures if Star Combo Pharma Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Star Combo Pharma Ltd to the Household & Personal Products industry mean.
  • A Quick Ratio of 6.30 means the company can pay off $6.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Star Combo Pharma Ltd:

  • The MRQ is 6.303. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.463. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.303TTM5.463+0.840
TTM5.463YOY5.684-0.221
TTM5.4635Y5.927-0.464
5Y5.92710Y4.980+0.948
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3030.761+5.542
TTM5.4630.768+4.695
YOY5.6840.772+4.912
5Y5.9270.872+5.055
10Y4.9800.919+4.061

1.4. Solvency of Star Combo Pharma Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Star Combo Pharma Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Star Combo Pharma Ltd to Household & Personal Products industry mean.
  • A Debt to Asset Ratio of 0.18 means that Star Combo Pharma Ltd assets are financed with 18.2% credit (debt) and the remaining percentage (100% - 18.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Star Combo Pharma Ltd:

  • The MRQ is 0.182. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.197. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.197-0.015
TTM0.197YOY0.182+0.015
TTM0.1975Y0.205-0.008
5Y0.20510Y0.207-0.002
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1820.448-0.266
TTM0.1970.459-0.262
YOY0.1820.463-0.281
5Y0.2050.446-0.241
10Y0.2070.448-0.241
1.4.2. Debt to Equity Ratio

Measures if Star Combo Pharma Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Star Combo Pharma Ltd to the Household & Personal Products industry mean.
  • A Debt to Equity ratio of 22.3% means that company has $0.22 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Star Combo Pharma Ltd:

  • The MRQ is 0.223. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.247. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.223TTM0.247-0.024
TTM0.247YOY0.223+0.024
TTM0.2475Y0.271-0.023
5Y0.27110Y0.281-0.010
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2230.787-0.564
TTM0.2470.802-0.555
YOY0.2230.789-0.566
5Y0.2710.821-0.550
10Y0.2810.841-0.560

2. Market Valuation of Star Combo Pharma Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Star Combo Pharma Ltd generates.

  • Above 15 is considered overpriced but always compare Star Combo Pharma Ltd to the Household & Personal Products industry mean.
  • A PE ratio of 38.95 means the investor is paying $38.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Star Combo Pharma Ltd:

  • The EOD is 32.238. Based on the earnings, the company is overpriced. -1
  • The MRQ is 38.954. Based on the earnings, the company is overpriced. -1
  • The TTM is 32.834. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD32.238MRQ38.954-6.716
MRQ38.954TTM32.834+6.120
TTM32.834YOY-10.026+42.860
TTM32.8345Y-1,927.599+1,960.433
5Y-1,927.59910Y-1,331.990-595.609
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD32.23818.603+13.635
MRQ38.95416.380+22.574
TTM32.83416.611+16.223
YOY-10.02620.049-30.075
5Y-1,927.59920.206-1,947.805
10Y-1,331.99022.487-1,354.477
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Star Combo Pharma Ltd:

  • The EOD is -34.425. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -41.597. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -20.528. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-34.425MRQ-41.597+7.172
MRQ-41.597TTM-20.528-21.069
TTM-20.528YOY-4.102-16.425
TTM-20.5285Y-12.866-7.662
5Y-12.86610Y-15.131+2.265
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-34.4259.318-43.743
MRQ-41.5979.830-51.427
TTM-20.52810.208-30.736
YOY-4.1025.777-9.879
5Y-12.86612.487-25.353
10Y-15.13112.477-27.608
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Star Combo Pharma Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • A PB ratio of 0.58 means the investor is paying $0.58 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Star Combo Pharma Ltd:

  • The EOD is 0.483. Based on the equity, the company is cheap. +2
  • The MRQ is 0.584. Based on the equity, the company is cheap. +2
  • The TTM is 0.465. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.483MRQ0.584-0.101
MRQ0.584TTM0.465+0.119
TTM0.465YOY0.686-0.221
TTM0.4655Y1.465-1.000
5Y1.46510Y1.644-0.179
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD0.4831.512-1.029
MRQ0.5841.711-1.127
TTM0.4651.787-1.322
YOY0.6862.000-1.314
5Y1.4652.083-0.618
10Y1.6442.816-1.172
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Star Combo Pharma Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Star Combo Pharma Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-100%-0.0060%0.006-100%0.009-100%
Book Value Per Share--0.2480.247+0%0.251-1%0.248+0%0.198+25%
Current Ratio--5.6744.927+15%5.436+4%5.6760%4.942+15%
Debt To Asset Ratio--0.1820.197-8%0.1820%0.205-11%0.207-12%
Debt To Equity Ratio--0.2230.247-10%0.223+0%0.271-17%0.281-20%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0010.001-8%-0.009+1102%-0.005+627%-0.004+556%
Free Cash Flow Per Share---0.0010.002-146%-0.014+1457%-0.010+1000%-0.007+719%
Free Cash Flow To Equity Per Share---0.0020.002-233%-0.014+532%-0.011+408%-0.006+189%
Gross Profit Margin--0.0090.014-37%1.196-99%25.958-100%18.630-100%
Intrinsic Value_10Y_max--1.354--------
Intrinsic Value_10Y_min--1.110--------
Intrinsic Value_1Y_max---0.013--------
Intrinsic Value_1Y_min---0.013--------
Intrinsic Value_3Y_max--0.073--------
Intrinsic Value_3Y_min--0.068--------
Intrinsic Value_5Y_max--0.297--------
Intrinsic Value_5Y_min--0.266--------
Market Cap16209960.960-21%19587036.16015534545.920+26%23357712.705-16%40967967.709-52%38850799.910-50%
Net Profit Margin--0.0100.019-45%-0.220+2238%-0.120+1270%-0.097+1040%
Operating Margin--0.0130.045-71%0.009+38%-0.024+287%-0.049+480%
Operating Ratio--0.9870.958+3%1.107-11%1.050-6%0.961+3%
Pb Ratio0.483-21%0.5840.465+26%0.686-15%1.465-60%1.644-64%
Pe Ratio32.238-21%38.95432.834+19%-10.026+126%-1927.599+5048%-1331.990+3519%
Price Per Share0.120-21%0.1450.115+26%0.173-16%0.303-52%0.287-50%
Price To Free Cash Flow Ratio-34.425+17%-41.597-20.528-51%-4.102-90%-12.866-69%-15.131-64%
Quick Ratio--6.3035.463+15%5.684+11%5.927+6%4.980+27%
Return On Assets--0.0030.004-29%-0.047+1636%-0.026+934%-0.021+770%
Return On Equity--0.0040.005-31%-0.058+1631%-0.032+938%-0.022+675%
Total Gains Per Share---0.002-100%-0.0060%0.006-100%0.009-100%
Usd Book Value--21793018.71221704157.885+0%22123078.876-1%21767440.273+0%17425247.301+25%
Usd Book Value Change Per Share---0.001-100%-0.0040%0.004-100%0.006-100%
Usd Book Value Per Share--0.1610.161+0%0.163-1%0.161+0%0.129+25%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0010.001-8%-0.006+1102%-0.003+627%-0.003+556%
Usd Free Cash Flow---76506.228165163.799-146%-1192072.251+1458%-842510.197+1001%-627209.974+720%
Usd Free Cash Flow Per Share---0.0010.001-146%-0.009+1457%-0.006+1000%-0.005+719%
Usd Free Cash Flow To Equity Per Share---0.0010.001-233%-0.009+532%-0.007+408%-0.004+189%
Usd Market Cap10534853.628-21%12729614.80010095901.393+26%15180177.487-16%26625082.214-52%25249134.861-50%
Usd Price Per Share0.078-21%0.0940.075+26%0.112-16%0.197-52%0.187-50%
Usd Profit--81695.680118237.932-31%-1232638.197+1609%-674846.395+926%-495550.857+707%
Usd Revenue--7951211.2996190716.686+28%5533730.988+44%5940325.748+34%4697293.637+69%
Usd Total Gains Per Share---0.001-100%-0.0040%0.004-100%0.006-100%
 EOD+3 -4MRQTTM+12 -21YOY+20 -95Y+23 -1010Y+23 -10

4.2. Fundamental Score

Let's check the fundamental score of Star Combo Pharma Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1532.238
Price to Book Ratio (EOD)Between0-10.483
Net Profit Margin (MRQ)Greater than00.010
Operating Margin (MRQ)Greater than00.013
Quick Ratio (MRQ)Greater than16.303
Current Ratio (MRQ)Greater than15.674
Debt to Asset Ratio (MRQ)Less than10.182
Debt to Equity Ratio (MRQ)Less than10.223
Return on Equity (MRQ)Greater than0.150.004
Return on Assets (MRQ)Greater than0.050.003
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Star Combo Pharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.120
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Other Stockholders Equity  -23,153-739-23,8920-23,89223,89201,6071,607
Total Other Income Expense Net -4,3194,249-70-28-9856-42171129



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets40,982
Total Liabilities7,449
Total Stockholder Equity33,349
 As reported
Total Liabilities 7,449
Total Stockholder Equity+ 33,349
Total Assets = 40,982

Assets

Total Assets40,982
Total Current Assets16,635
Long-term Assets24,347
Total Current Assets
Cash And Cash Equivalents 3,169
Short-term Investments 6,019
Net Receivables 3,271
Inventory 3,964
Other Current Assets 213
Total Current Assets  (as reported)16,635
Total Current Assets  (calculated)16,635
+/-0
Long-term Assets
Property Plant Equipment 22,934
Intangible Assets 684
Long-term Assets Other 729
Long-term Assets  (as reported)24,347
Long-term Assets  (calculated)24,347
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,932
Long-term Liabilities4,518
Total Stockholder Equity33,349
Total Current Liabilities
Short-term Debt 157
Accounts payable 2,409
Other Current Liabilities 334
Total Current Liabilities  (as reported)2,932
Total Current Liabilities  (calculated)2,900
+/- 31
Long-term Liabilities
Long-term Liabilities  (as reported)4,518
Long-term Liabilities  (calculated)0
+/- 4,518
Total Stockholder Equity
Common Stock67,293
Retained Earnings -35,547
Accumulated Other Comprehensive Income -4
Other Stockholders Equity 1,607
Total Stockholder Equity (as reported)33,349
Total Stockholder Equity (calculated)33,349
+/-0
Other
Cash and Short Term Investments 9,188
Common Stock Shares Outstanding 135,083
Current Deferred Revenue31
Liabilities and Stockholders Equity 40,982
Net Debt 940
Net Working Capital 13,704
Short Long Term Debt Total 4,109



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-09-302016-06-30
> Total Assets 
7,090
0
15,470
15,470
16,095
16,095
19,367
19,367
18,818
18,818
26,787
27,506
30,604
30,604
54,716
54,716
51,236
51,236
43,322
43,322
43,049
43,049
43,443
43,443
39,789
39,789
42,227
42,227
40,982
40,982
40,98240,98242,22742,22739,78939,78943,44343,44343,04943,04943,32243,32251,23651,23654,71654,71630,60430,60427,50626,78718,81818,81819,36719,36716,09516,09515,47015,47007,090
   > Total Current Assets 
0
0
0
0
6,206
12,796
15,681
15,681
15,187
15,187
12,778
12,778
11,685
11,685
35,340
35,340
28,516
28,516
26,427
26,427
25,346
25,346
19,080
19,080
16,466
16,466
18,104
18,104
16,635
16,635
16,63516,63518,10418,10416,46616,46619,08019,08025,34625,34626,42726,42728,51628,51635,34035,34011,68511,68512,77812,77815,18715,18715,68115,68112,7966,2060000
       Cash And Cash Equivalents 
0
0
0
0
-6,206
5,447
8,942
8,942
7,786
7,786
4,621
4,621
2,354
2,354
26,601
26,601
5,005
5,005
7,272
17,322
3,612
3,612
4,392
10,392
2,586
2,586
2,987
9,487
3,169
3,169
3,1693,1699,4872,9872,5862,58610,3924,3923,6123,61217,3227,2725,0055,00526,60126,6012,3542,3544,6214,6217,7867,7868,9428,9425,447-6,2060000
       Short-term Investments 
0
0
0
0
12,412
0
0
0
0
0
0
0
133
133
0
0
15,015
15,015
10,050
0
10,050
10,050
6,000
6,000
6,000
6,000
6,500
6,500
6,019
6,019
6,0196,0196,5006,5006,0006,0006,0006,00010,05010,050010,05015,01515,01500133133000000012,4120000
       Net Receivables 
1,996
0
4,100
4,100
3,750
3,750
2,504
2,504
2,436
2,436
2,487
2,816
2,586
3,162
2,333
2,525
3,267
3,552
2,001
4,404
6,619
6,660
1,984
3,179
3,245
3,331
3,787
4,298
3,271
3,271
3,2713,2714,2983,7873,3313,2453,1791,9846,6606,6194,4042,0013,5523,2672,5252,3333,1622,5862,8162,4872,4362,4362,5042,5043,7503,7504,1004,10001,996
       Other Current Assets 
9
0
32
32
197
197
766
766
1,044
1,044
732
350
1,299
724
1,026
662
397
113
2,601
157
194
153
1,332
137
240
154
632
121
213
213
2132131216321542401371,3321531941572,6011133976621,0267241,2993507321,0441,044766766197197323209
   > Long-term Assets 
0
0
0
0
0
0
3,186
3,186
3,131
3,131
12,476
14,728
17,420
18,919
17,916
19,377
21,341
22,720
15,998
16,895
16,825
17,703
23,440
24,363
22,545
23,324
24,123
24,123
24,347
24,347
24,34724,34724,12324,12323,32422,54524,36323,44017,70316,82516,89515,99822,72021,34119,37717,91618,91917,42014,72812,4763,1313,1313,1863,186000000
       Property Plant Equipment 
2,603
0
2,594
2,594
2,506
2,506
2,521
2,521
2,466
2,466
2,942
2,942
8,004
8,004
8,686
8,686
12,300
12,300
13,485
13,485
14,501
14,501
22,741
22,741
21,852
21,852
22,723
22,723
22,934
22,934
22,93422,93422,72322,72321,85221,85222,74122,74114,50114,50113,48513,48512,30012,3008,6868,6868,0048,0042,9422,9422,4662,4662,5212,5212,5062,5062,5942,59402,603
       Goodwill 
0
0
0
0
0
0
0
0
0
0
6,338
7,477
6,338
6,338
6,338
6,338
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000006,3386,3386,3386,3387,4776,3380000000000
       Intangible Assets 
0
0
0
0
623
623
665
665
665
665
3,197
3,197
3,078
9,040
2,892
2,892
9,040
2,324
2,513
2,513
2,324
693
700
700
693
693
690
690
684
684
6846846906906936937007006932,3242,5132,5132,3249,0402,8922,8929,0403,0783,1973,1976656656656656236230000
       Long-term Assets Other 
0
0
0
0
0
0
-3,186
-3,186
-3,131
-3,131
-12,476
14,728
-17,420
375
-17,916
0
-21,341
6,716
-15,998
0
-16,825
1,631
-23,440
-23,440
-22,545
-22,545
710
-23,413
729
729
729729-23,413710-22,545-22,545-23,440-23,4401,631-16,8250-15,9986,716-21,3410-17,916375-17,42014,728-12,476-3,131-3,131-3,186-3,186000000
> Total Liabilities 
3,206
0
5,021
5,021
6,102
6,102
2,763
2,763
2,022
2,022
6,715
7,506
11,968
11,968
10,218
10,218
6,642
6,642
7,129
7,129
6,943
6,943
8,038
8,038
7,113
7,113
8,968
8,968
7,449
7,449
7,4497,4498,9688,9687,1137,1138,0388,0386,9436,9437,1297,1296,6426,64210,21810,21811,96811,9687,5066,7152,0222,0222,7632,7636,1026,1025,0215,02103,206
   > Total Current Liabilities 
2,073
0
4,425
4,425
5,671
5,671
2,763
2,763
2,012
2,012
4,871
5,522
5,922
5,922
4,664
4,664
3,070
3,070
3,547
3,547
3,484
3,484
4,008
4,008
2,694
2,694
4,332
4,332
2,932
2,932
2,9322,9324,3324,3322,6942,6944,0084,0083,4843,4843,5473,5473,0703,0704,6644,6645,9225,9225,5224,8712,0122,0122,7632,7635,6715,6714,4254,42502,073
       Short-term Debt 
0
0
0
0
325
325
136
136
0
0
0
0
136
319
0
665
0
160
0
175
0
180
0
170
0
172
37
164
20
157
157201643717201700180017501600665031913600001361363253250000
       Short Long Term Debt 
0
0
0
0
325
325
136
136
0
0
0
0
136
136
0
485
0
0
0
32
0
0
0
35
0
0
0
37
0
0
00370003500032000485013613600001361363253250000
       Accounts payable 
899
0
1,402
1,402
2,587
2,587
1,717
1,717
1,378
1,378
2,373
2,383
4,151
4,151
2,033
2,033
2,707
2,707
2,118
2,118
3,070
3,070
2,337
2,337
2,284
2,284
2,439
2,439
2,409
2,409
2,4092,4092,4392,4392,2842,2842,3372,3373,0703,0702,1182,1182,7072,7072,0332,0334,1514,1512,3832,3731,3781,3781,7171,7172,5872,5871,4021,4020899
       Other Current Liabilities 
1,058
0
1,990
1,990
1,791
1,791
1,046
1,046
634
634
2,498
3,138
1,771
1,452
2,631
928
363
203
1,429
1,254
415
235
1,671
1,501
410
238
1,856
1,730
502
334
3345021,7301,8562384101,5011,6712354151,2541,4292033639282,6311,4521,7713,1382,4986346341,0461,0461,7911,7911,9901,99001,058
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
48
1,985
617
6,046
1,586
5,553
85
3,572
116
3,583
98
3,458
80
4,030
0
4,419
4,635
4,635
4,518
4,518
4,5184,5184,6354,6354,41904,030803,458983,5831163,572855,5531,5866,0466171,985480000000000
       Long term Debt Total 
0
0
0
0
0
430
0
0
0
0
0
48
0
4,070
0
4,949
0
3,052
0
3,121
0
3,028
0
3,951
0
3,812
0
4,028
0
0
004,02803,81203,95103,02803,12103,05204,94904,0700480000043000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-325
-325
-136
-136
0
0
0
0
-136
-319
0
2,878
0
-160
0
2,974
0
-180
0
3,837
0
-172
-37
3,982
-20
-157
-157-203,982-37-17203,8370-18002,9740-16002,8780-319-1360000-136-136-325-3250000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
1,194
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
536
0
0
005360000000000000001,19400000000000
> Total Stockholder Equity
3,884
3,884
10,449
10,449
10,449
9,992
16,591
16,591
16,796
16,796
20,072
19,999
18,636
18,636
44,499
44,499
44,593
44,593
36,193
36,193
36,106
36,106
35,405
35,405
32,506
32,506
33,094
33,094
33,349
33,349
33,34933,34933,09433,09432,50632,50635,40535,40536,10636,10636,19336,19344,59344,59344,49944,49918,63618,63619,99920,07216,79616,79616,59116,5919,99210,44910,44910,4493,8843,884
   Common Stock
1
0
5,001
5,001
5,001
5,001
37,325
37,325
39,160
39,160
42,761
42,761
42,761
42,761
67,743
67,743
67,322
67,322
67,322
67,322
67,216
67,216
67,216
67,216
67,292
67,292
67,293
67,293
67,293
67,293
67,29367,29367,29367,29367,29267,29267,21667,21667,21667,21667,32267,32267,32267,32267,74367,74342,76142,76142,76142,76139,16039,16037,32537,3255,0015,0015,0015,00101
   Retained Earnings 
3,883
0
5,448
5,448
4,991
4,991
2,908
2,908
1,608
1,608
1,372
1,300
351
-25,148
1,235
1,235
1,765
-23,734
-6,512
-6,512
-6,513
-32,012
-7,056
-7,056
-11,633
-37,132
-10,306
-10,306
-10,048
-35,547
-35,547-10,048-10,306-10,306-37,132-11,633-7,056-7,056-32,012-6,513-6,512-6,512-23,7341,7651,2351,235-25,1483511,3001,3721,6081,6082,9082,9084,9914,9915,4485,44803,883
   Capital Surplus 000000000000000000000000000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
-23,643
-23,643
-23,973
-23,973
-24,061
1
-24,476
-24,476
-24,479
-24,479
-24,494
-24,494
-24,618
-24,618
-24,597
0
-24,755
-24,755
-23,153
-23,153
-23,892
-23,892
0
1,607
1,6070-23,892-23,892-23,153-23,153-24,755-24,7550-24,597-24,618-24,618-24,494-24,494-24,479-24,479-24,476-24,4761-24,061-23,973-23,973-23,643-23,643000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue24,700
Cost of Revenue-17,540
Gross Profit7,1607,160
 
Operating Income (+$)
Gross Profit7,160
Operating Expense-6,328
Operating Income1,145832
 
Operating Expense (+$)
Research Development0
Selling General Administrative3,265
Selling And Marketing Expenses527
Operating Expense6,3283,792
 
Net Interest Income (+$)
Interest Income234
Interest Expense-187
Other Finance Cost-105
Net Interest Income-58
 
Pretax Income (+$)
Operating Income1,145
Net Interest Income-58
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,4555,503
EBIT - interestExpense = 958
-3,455
-3,816
Interest Expense187
Earnings Before Interest and Taxes (EBIT)1,145-3,268
Earnings Before Interest and Taxes (EBITDA)1,885
 
After tax Income (+$)
Income Before Tax-3,455
Tax Provision-548
Net Income From Continuing Ops-4,003-4,003
Net Income-4,003
Net Income Applicable To Common Shares-4,003
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses23,868
Total Other Income/Expenses Net-4,35858
 

Technical Analysis of Star Combo Pharma Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Star Combo Pharma Ltd. The general trend of Star Combo Pharma Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Star Combo Pharma Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Star Combo Pharma Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.12 < 0.12 < 0.12.

The bearish price targets are: 0.12 > 0.12 > 0.12.

Tweet this
Star Combo Pharma Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Star Combo Pharma Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Star Combo Pharma Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Moving Average Convergence/Divergence (MACD) ChartStar Combo Pharma Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Star Combo Pharma Ltd. The current adx is .

Star Combo Pharma Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Relative Strength Index (RSI) ChartStar Combo Pharma Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Stochastic Oscillator ChartStar Combo Pharma Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Commodity Channel Index (CCI) ChartStar Combo Pharma Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Chande Momentum Oscillator (CMO) ChartStar Combo Pharma Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Williams %R ChartStar Combo Pharma Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Average True Range (ATR) ChartStar Combo Pharma Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily On-Balance Volume (OBV) ChartStar Combo Pharma Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Star Combo Pharma Ltd.

Star Combo Pharma Ltd Daily Money Flow Index (MFI) ChartStar Combo Pharma Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Star Combo Pharma Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Star Combo Pharma Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Star Combo Pharma Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.120
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Star Combo Pharma Ltd with someone you think should read this too:
  • Are you bullish or bearish on Star Combo Pharma Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Star Combo Pharma Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Star Combo Pharma Ltd

I send you an email if I find something interesting about Star Combo Pharma Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Star Combo Pharma Ltd.

Receive notifications about Star Combo Pharma Ltd in your mailbox!